Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Aphelion Capital

Investor type Micro VC
Founders Ned Scheetz


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 32
Average round size
The average size of a deal this fund participated in
Portfolio companies 21
Rounds per year 1.88
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 7
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical Device
  • Medical
  • Biotechnology
  • Software

In 2005 was created Aphelion Capital, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Mill Valley.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Aphelion Capital, startups are often financed by Stanmore Medical Investments, TL Ventures, Research Corporation Technologies. The meaningful sponsors for the fund in investment in the same round are California Technology Ventures, River Cities Capital Funds, Research Corporation Technologies. In the next rounds fund is usually obtained by Ameritas Life Insurance, Tallwood Venture Capital, Synopsys.

The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. Considering the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2011. Comparing to the other companies, this Aphelion Capital performs on 7 percentage points less the average number of lead investments.

The fund was created by Ned Scheetz. We also calculated 2 valuable employees in our database.

Among the various public portfolio startups of the fund, we may underline CytoPherx, Providence Medical Technology, VasoNova We can highlight the next thriving fund investment areas, such as Software, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Aphelion Capital:
Typical Co-investors
Aphelion Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Aphelion Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Artha99 Investment Partners Chennai, India, Tamil Nadu
Awin Berlin, Berlin, Germany
Business Model Competition -
Chowning Group Houston, Texas, United States
Galactic.VC -
GigaMedia Taipei, Taiwan
Globis Chiyoda, Japan
Hack Secure Boston, Massachusetts, United States
Hartnett Enterprise Acceleration Centre County Limerick, Ireland, Limerick
Mawson Ventures -
Optimpharma -
Patni Family -
Sagene Tech Ventures Norway, Oslo
Sood Ventures California, Palo Alto, United States
Suzhou Botao Chuang tou China, Jiangsu, Suzhou
Techcelerator Bucharest, Bucuresti, Romania
Thayer Street Partners New York, New York, United States
Tullis Health Investors Connecticut, Stamford, United States
WPG Holdings Taipei, Taiwan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Moving Analytics

Health Care
Information Technology
$20M08 Jul 2022 Los Angeles, California, United States

Moving Analytics

Health Care
Information Technology
$6M19 Apr 2021 Los Angeles, California, United States

ExplORer Surgical

Clinical Trials
Health Care
Medical Device
$2M09 Apr 2021 Chicago, Illinois, United States

MIVI Neuroscience

Health Care
Medical Device
$35M21 Jan 2021 Minnesota, United States

Koya Medical

Health Care
$11M14 Jan 2021 Oakland, California, United States

Orpyx Medical Technologies

Health Care
Medical Device
Personal Health
$7M08 Jul 2020 Canada


Health Care
Information Technology
Product Design
$7M10 Mar 2020 San Jose, California, United States

ExplORer Surgical

Clinical Trials
Health Care
Medical Device
$5M18 Apr 2019 Chicago, Illinois, United States

Bardy Diagnostics

Health Care
Health Diagnostics
Medical Device
$35M16 Apr 2019 Seattle, Washington, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Aphelion Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: